Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204062495> ?p ?o ?g. }
- W3204062495 endingPage "1563" @default.
- W3204062495 startingPage "1550" @default.
- W3204062495 abstract "Patients undergoing early surgery after coronary stent implantation are at increased risk for mortality from ischemic and hemorrhagic complications. The optimal antiplatelet strategy in patients who cannot discontinue dual antiplatelet therapy (DAPT) before surgery is unclear. Current guidelines, based on surgical and clinical characteristics, provide risk stratification for bridging therapy with intravenous antiplatelet agents, but management is guided primarily by expert opinion. This review summarizes perioperative risk factors to consider before discontinuing DAPT and reviews the data for intravenous bridging therapies. Published reports have included bridging options such as small molecule glycoprotein IIb/IIIa inhibitors (eptifibatide or tirofiban) and cangrelor, an intravenous P2Y12 inhibitor. However, optimal management of these complex patients remains unclear in the absence of randomized controlled data, without which an argument can be made both for and against the use of perioperative intravenous bridging therapy after discontinuing oral P2Y12 inhibitors. Multidisciplinary risk assessment remains a critical component of perioperative care." @default.
- W3204062495 created "2021-10-11" @default.
- W3204062495 creator A5002965075 @default.
- W3204062495 creator A5006133112 @default.
- W3204062495 creator A5013173022 @default.
- W3204062495 creator A5016139987 @default.
- W3204062495 creator A5018963320 @default.
- W3204062495 creator A5020539611 @default.
- W3204062495 creator A5026004870 @default.
- W3204062495 creator A5026399707 @default.
- W3204062495 creator A5040418600 @default.
- W3204062495 creator A5045761776 @default.
- W3204062495 creator A5074500725 @default.
- W3204062495 creator A5079070292 @default.
- W3204062495 creator A5083843089 @default.
- W3204062495 date "2021-10-01" @default.
- W3204062495 modified "2023-10-18" @default.
- W3204062495 title "Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention" @default.
- W3204062495 cites W1594634064 @default.
- W3204062495 cites W1980346468 @default.
- W3204062495 cites W1990212998 @default.
- W3204062495 cites W1991657560 @default.
- W3204062495 cites W1993578099 @default.
- W3204062495 cites W1994478916 @default.
- W3204062495 cites W2016869940 @default.
- W3204062495 cites W2019318370 @default.
- W3204062495 cites W2029655742 @default.
- W3204062495 cites W2056085074 @default.
- W3204062495 cites W2059757910 @default.
- W3204062495 cites W2065390746 @default.
- W3204062495 cites W2067433890 @default.
- W3204062495 cites W2068295374 @default.
- W3204062495 cites W2116794265 @default.
- W3204062495 cites W2128817575 @default.
- W3204062495 cites W2129435364 @default.
- W3204062495 cites W2132281623 @default.
- W3204062495 cites W2143277746 @default.
- W3204062495 cites W2150655309 @default.
- W3204062495 cites W2184720681 @default.
- W3204062495 cites W2315912882 @default.
- W3204062495 cites W2322750923 @default.
- W3204062495 cites W2329082005 @default.
- W3204062495 cites W2329837630 @default.
- W3204062495 cites W2331542415 @default.
- W3204062495 cites W2331820709 @default.
- W3204062495 cites W23578566 @default.
- W3204062495 cites W2436221345 @default.
- W3204062495 cites W2480930200 @default.
- W3204062495 cites W2542865118 @default.
- W3204062495 cites W2565424709 @default.
- W3204062495 cites W2604440838 @default.
- W3204062495 cites W2619612989 @default.
- W3204062495 cites W2750208807 @default.
- W3204062495 cites W2752033985 @default.
- W3204062495 cites W2769988420 @default.
- W3204062495 cites W2777614036 @default.
- W3204062495 cites W2789272589 @default.
- W3204062495 cites W2791385973 @default.
- W3204062495 cites W2807160752 @default.
- W3204062495 cites W2809976815 @default.
- W3204062495 cites W2888227991 @default.
- W3204062495 cites W2900684021 @default.
- W3204062495 cites W2921627848 @default.
- W3204062495 cites W2976166882 @default.
- W3204062495 cites W3025270873 @default.
- W3204062495 cites W4237892021 @default.
- W3204062495 cites W56850546 @default.
- W3204062495 doi "https://doi.org/10.1016/j.jacc.2021.08.013" @default.
- W3204062495 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34620413" @default.
- W3204062495 hasPublicationYear "2021" @default.
- W3204062495 type Work @default.
- W3204062495 sameAs 3204062495 @default.
- W3204062495 citedByCount "15" @default.
- W3204062495 countsByYear W32040624952022 @default.
- W3204062495 countsByYear W32040624952023 @default.
- W3204062495 crossrefType "journal-article" @default.
- W3204062495 hasAuthorship W3204062495A5002965075 @default.
- W3204062495 hasAuthorship W3204062495A5006133112 @default.
- W3204062495 hasAuthorship W3204062495A5013173022 @default.
- W3204062495 hasAuthorship W3204062495A5016139987 @default.
- W3204062495 hasAuthorship W3204062495A5018963320 @default.
- W3204062495 hasAuthorship W3204062495A5020539611 @default.
- W3204062495 hasAuthorship W3204062495A5026004870 @default.
- W3204062495 hasAuthorship W3204062495A5026399707 @default.
- W3204062495 hasAuthorship W3204062495A5040418600 @default.
- W3204062495 hasAuthorship W3204062495A5045761776 @default.
- W3204062495 hasAuthorship W3204062495A5074500725 @default.
- W3204062495 hasAuthorship W3204062495A5079070292 @default.
- W3204062495 hasAuthorship W3204062495A5083843089 @default.
- W3204062495 hasConcept C126322002 @default.
- W3204062495 hasConcept C141071460 @default.
- W3204062495 hasConcept C174348530 @default.
- W3204062495 hasConcept C177713679 @default.
- W3204062495 hasConcept C2776335557 @default.
- W3204062495 hasConcept C2776708134 @default.
- W3204062495 hasConcept C2777871224 @default.
- W3204062495 hasConcept C2779637338 @default.
- W3204062495 hasConcept C2780400711 @default.